phosphorylation.of Bcr serine kinase by tyrosine

[1]  C. Sawyers,et al.  Differential complementation of Bcr-Abl point mutants with c-Myc. , 1994, Science.

[2]  T Pawson,et al.  Bcr‐Abl oncoproteins bind directly to activators of the Ras signalling pathway. , 1994, The EMBO journal.

[3]  Nanxin Li,et al.  BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein , 1993, Cell.

[4]  D. Bar-Sagi,et al.  Grb2 mediates the EGF-dependent activation of guanine nucleotide exchange on Ras , 1993, Nature.

[5]  O. Witte,et al.  SH1 domain autophosphorylation of P210 BCR/ABL is required for transformation but not growth factor independence , 1993, Molecular and cellular biology.

[6]  O. Witte,et al.  The BCR gene encodes a novel serine/threonine kinase activity within a single exon , 1991, Cell.

[7]  T. Wong,et al.  A manual sequencing method for identification of phosphorylated amino acids in phosphopeptides. , 1991, Analytical biochemistry.

[8]  J. Wang,et al.  Activation of tyrosinase kinase and microfilament-binding functions of c-abl by bcr sequences in bcr/abl fusion proteins , 1991, Molecular and cellular biology.

[9]  G. Jenster,et al.  Acute leukaemia in bcr/abl transgenic mice , 1990, Nature.

[10]  G. Daley,et al.  Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome. , 1990, Science.

[11]  R. Gale,et al.  Characterization of bcr gene products in hematopoietic cells. , 1989, Oncogene.

[12]  D. Shalloway,et al.  Altered phosphorylation and activation of PP60c-src during fibroblast mitosis , 1988, Cell.

[13]  N. Heisterkamp,et al.  Evidence that the phl gene encodes a 160,000-dalton phosphoprotein with associated kinase activity. , 1987, Molecular and cellular biology.

[14]  N. Heisterkamp,et al.  Evidence of a new chimeric bcr/c-abl mRNA in patients with chronic myelocytic leukemia and the Philadelphia chromosome. , 1985, The New England journal of medicine.

[15]  E. Canaani,et al.  Fused transcript of abl and bcr genes in chronic myelogenous leukaemia , 1985, Nature.

[16]  R. Kurzrock,et al.  The human cellular abl gene product in the chronic myelogenous leukemia cell line K562 has an associated tyrosine protein kinase activity. , 1985, Virology.

[17]  Susan M. Watanabe,et al.  An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity , 1984, Cell.

[18]  A. Annamalai,et al.  Reaction of the adenine nucleotide analogue 5'-p-fluorosulfonylbenzoyl adenosine at distinct tyrosine and cysteine residues of rabbit muscle pyruvate kinase. , 1981, The Journal of biological chemistry.

[19]  T. Hunter,et al.  Transforming gene product of Rous sarcoma virus phosphorylates tyrosine , 1980, Proceedings of the National Academy of Sciences.

[20]  M. Campbell,et al.  BCR-ABL tyrosine kinase is autophosphorylated or transphosphorylates P160 BCR on tyrosine predominantly within the first BCR exon. , 1993, Oncogene.

[21]  J. Nickoloff,et al.  Site-directed mutagenesis of virtually any plasmid by eliminating a unique site. , 1992, Analytical biochemistry.

[22]  M. Campbell,et al.  Current status of the BCR gene and its involvement with human leukemia. , 1991, Advances in cancer research.

[23]  Jonathan A. Cooper,et al.  6 Viral Oncogenes and Tyrosine Phosphorylation , 1986 .